Selected research
Industry Research
Pharmaceutical Anti-Counterfeiting Solution Industry Research Report 2026
Market perspective
The global Pharmaceutical Anti-Counterfeiting Solution market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Pharmaceutical Anti-Counterfeiting Solution market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Pharmaceutical Anti-Counterfeiting Solution market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Pharmaceutical Anti-Counterfeiting Solution market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Pharmaceutical Anti-Counterfeiting Solution include SICPA, Alpvision, 3M, Cypheme, Systech, Authentix, Avery Dennison Corporation, NanoMatriX and Covectra, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Pharmaceutical Anti-Counterfeiting Solution market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pharmaceutical Anti-Counterfeiting Solution.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pharmaceutical Anti-Counterfeiting Solution Market by Company
SICPA
Alpvision
3M
Cypheme
Systech
Authentix
Avery Dennison Corporation
NanoMatriX
Covectra
DS Smith
NeuroTags
U-NICA
Constantia Flexibles
Arjo Solution
SafeTraces
Pharmaceutical Anti-Counterfeiting Solution Segment by Type
Authentication Technology
Track & Trace Technology
Others
Pharmaceutical Anti-Counterfeiting Solution Segment by Application
Medical & Pharmaceutical
Package Industry
Logistics Industry
Others
Pharmaceutical Anti-Counterfeiting Solution Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Anti-Counterfeiting Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Anti-Counterfeiting Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Anti-Counterfeiting Solution.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pharmaceutical Anti-Counterfeiting Solution companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Authentication Technology
- Track & Trace Technology
- Others
Applications
- Medical & Pharmaceutical
- Package Industry
- Logistics Industry
- Others
Companies covered
- SICPA
- Alpvision
- 3M
- Cypheme
- Systech
- Authentix
- Avery Dennison Corporation
- NanoMatriX
- Covectra
- DS Smith
- NeuroTags
- U-NICA
- Constantia Flexibles
- Arjo Solution
- SafeTraces
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pharmaceutical Anti-Counterfeiting Solution by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Authentication Technology
- 2.2.3 Track & Trace Technology
- 2.2.4 Others
- 2.3 Pharmaceutical Anti-Counterfeiting Solution by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Medical & Pharmaceutical
- 2.3.3 Package Industry
- 2.3.4 Logistics Industry
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Pharmaceutical Anti-Counterfeiting Solution Breakdown Data by Type
- 3.1 Global Pharmaceutical Anti-Counterfeiting Solution Historic Market Size by Type (2021-2026)
- 3.2 Global Pharmaceutical Anti-Counterfeiting Solution Forecasted Market Size by Type (2027-2032)
4 Pharmaceutical Anti-Counterfeiting Solution Breakdown Data by Application
- 4.1 Global Pharmaceutical Anti-Counterfeiting Solution Historic Market Size by Application (2021-2026)
- 4.2 Global Pharmaceutical Anti-Counterfeiting Solution Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Pharmaceutical Anti-Counterfeiting Solution Market Perspective (2021-2032)
- 5.2 Global Pharmaceutical Anti-Counterfeiting Solution Growth Trends by Region
- 5.2.1 Global Pharmaceutical Anti-Counterfeiting Solution Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Pharmaceutical Anti-Counterfeiting Solution Historic Market Size by Region (2021-2026)
- 5.2.3 Pharmaceutical Anti-Counterfeiting Solution Forecasted Market Size by Region (2027-2032)
- 5.3 Pharmaceutical Anti-Counterfeiting Solution Market Dynamics
- 5.3.1 Pharmaceutical Anti-Counterfeiting Solution Industry Trends
- 5.3.2 Pharmaceutical Anti-Counterfeiting Solution Market Drivers
- 5.3.3 Pharmaceutical Anti-Counterfeiting Solution Market Challenges
- 5.3.4 Pharmaceutical Anti-Counterfeiting Solution Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Pharmaceutical Anti-Counterfeiting Solution Players by Revenue
- 6.1.1 Global Top Pharmaceutical Anti-Counterfeiting Solution Players by Revenue (2021-2026)
- 6.1.2 Global Pharmaceutical Anti-Counterfeiting Solution Revenue Market Share by Players (2021-2026)
- 6.2 Global Pharmaceutical Anti-Counterfeiting Solution Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Pharmaceutical Anti-Counterfeiting Solution Head Office and Area Served
- 6.4 Global Pharmaceutical Anti-Counterfeiting Solution Players, Product Type & Application
- 6.5 Global Pharmaceutical Anti-Counterfeiting Solution Manufacturers Established Date
- 6.6 Global Pharmaceutical Anti-Counterfeiting Solution Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Pharmaceutical Anti-Counterfeiting Solution Market Size (2021-2032)
- 7.2 North America Pharmaceutical Anti-Counterfeiting Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Pharmaceutical Anti-Counterfeiting Solution Market Size by Country (2021-2026)
- 7.4 North America Pharmaceutical Anti-Counterfeiting Solution Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Pharmaceutical Anti-Counterfeiting Solution Market Size (2021-2032)
- 8.2 Europe Pharmaceutical Anti-Counterfeiting Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Pharmaceutical Anti-Counterfeiting Solution Market Size by Country (2021-2026)
- 8.4 Europe Pharmaceutical Anti-Counterfeiting Solution Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Pharmaceutical Anti-Counterfeiting Solution Market Size (2021-2032)
- 9.2 Asia-Pacific Pharmaceutical Anti-Counterfeiting Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Pharmaceutical Anti-Counterfeiting Solution Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Pharmaceutical Anti-Counterfeiting Solution Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Pharmaceutical Anti-Counterfeiting Solution Market Size (2021-2032)
- 10.2 South America Pharmaceutical Anti-Counterfeiting Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Pharmaceutical Anti-Counterfeiting Solution Market Size by Country (2021-2026)
- 10.4 South America Pharmaceutical Anti-Counterfeiting Solution Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Pharmaceutical Anti-Counterfeiting Solution Market Size (2021-2032)
- 11.2 Middle East & Africa Pharmaceutical Anti-Counterfeiting Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Pharmaceutical Anti-Counterfeiting Solution Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Pharmaceutical Anti-Counterfeiting Solution Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 SICPA
- 12.1.1 SICPA Company Information
- 12.1.2 SICPA Business Overview
- 12.1.3 SICPA Revenue in Pharmaceutical Anti-Counterfeiting Solution Business (2021-2026)
- 12.1.4 SICPA Pharmaceutical Anti-Counterfeiting Solution Product Portfolio
- 12.1.5 SICPA Recent Developments
- 12.2 Alpvision
- 12.2.1 Alpvision Company Information
- 12.2.2 Alpvision Business Overview
- 12.2.3 Alpvision Revenue in Pharmaceutical Anti-Counterfeiting Solution Business (2021-2026)
- 12.2.4 Alpvision Pharmaceutical Anti-Counterfeiting Solution Product Portfolio
- 12.2.5 Alpvision Recent Developments
- 12.3 3M
- 12.3.1 3M Company Information
- 12.3.2 3M Business Overview
- 12.3.3 3M Revenue in Pharmaceutical Anti-Counterfeiting Solution Business (2021-2026)
- 12.3.4 3M Pharmaceutical Anti-Counterfeiting Solution Product Portfolio
- 12.3.5 3M Recent Developments
- 12.4 Cypheme
- 12.4.1 Cypheme Company Information
- 12.4.2 Cypheme Business Overview
- 12.4.3 Cypheme Revenue in Pharmaceutical Anti-Counterfeiting Solution Business (2021-2026)
- 12.4.4 Cypheme Pharmaceutical Anti-Counterfeiting Solution Product Portfolio
- 12.4.5 Cypheme Recent Developments
- 12.5 Systech
- 12.5.1 Systech Company Information
- 12.5.2 Systech Business Overview
- 12.5.3 Systech Revenue in Pharmaceutical Anti-Counterfeiting Solution Business (2021-2026)
- 12.5.4 Systech Pharmaceutical Anti-Counterfeiting Solution Product Portfolio
- 12.5.5 Systech Recent Developments
- 12.6 Authentix
- 12.6.1 Authentix Company Information
- 12.6.2 Authentix Business Overview
- 12.6.3 Authentix Revenue in Pharmaceutical Anti-Counterfeiting Solution Business (2021-2026)
- 12.6.4 Authentix Pharmaceutical Anti-Counterfeiting Solution Product Portfolio
- 12.6.5 Authentix Recent Developments
- 12.7 Avery Dennison Corporation
- 12.7.1 Avery Dennison Corporation Company Information
- 12.7.2 Avery Dennison Corporation Business Overview
- 12.7.3 Avery Dennison Corporation Revenue in Pharmaceutical Anti-Counterfeiting Solution Business (2021-2026)
- 12.7.4 Avery Dennison Corporation Pharmaceutical Anti-Counterfeiting Solution Product Portfolio
- 12.7.5 Avery Dennison Corporation Recent Developments
- 12.8 NanoMatriX
- 12.8.1 NanoMatriX Company Information
- 12.8.2 NanoMatriX Business Overview
- 12.8.3 NanoMatriX Revenue in Pharmaceutical Anti-Counterfeiting Solution Business (2021-2026)
- 12.8.4 NanoMatriX Pharmaceutical Anti-Counterfeiting Solution Product Portfolio
- 12.8.5 NanoMatriX Recent Developments
- 12.9 Covectra
- 12.9.1 Covectra Company Information
- 12.9.2 Covectra Business Overview
- 12.9.3 Covectra Revenue in Pharmaceutical Anti-Counterfeiting Solution Business (2021-2026)
- 12.9.4 Covectra Pharmaceutical Anti-Counterfeiting Solution Product Portfolio
- 12.9.5 Covectra Recent Developments
- 12.10 DS Smith
- 12.10.1 DS Smith Company Information
- 12.10.2 DS Smith Business Overview
- 12.10.3 DS Smith Revenue in Pharmaceutical Anti-Counterfeiting Solution Business (2021-2026)
- 12.10.4 DS Smith Pharmaceutical Anti-Counterfeiting Solution Product Portfolio
- 12.10.5 DS Smith Recent Developments
- 12.11 NeuroTags
- 12.11.1 NeuroTags Company Information
- 12.11.2 NeuroTags Business Overview
- 12.11.3 NeuroTags Revenue in Pharmaceutical Anti-Counterfeiting Solution Business (2021-2026)
- 12.11.4 NeuroTags Pharmaceutical Anti-Counterfeiting Solution Product Portfolio
- 12.11.5 NeuroTags Recent Developments
- 12.12 U-NICA
- 12.12.1 U-NICA Company Information
- 12.12.2 U-NICA Business Overview
- 12.12.3 U-NICA Revenue in Pharmaceutical Anti-Counterfeiting Solution Business (2021-2026)
- 12.12.4 U-NICA Pharmaceutical Anti-Counterfeiting Solution Product Portfolio
- 12.12.5 U-NICA Recent Developments
- 12.13 Constantia Flexibles
- 12.13.1 Constantia Flexibles Company Information
- 12.13.2 Constantia Flexibles Business Overview
- 12.13.3 Constantia Flexibles Revenue in Pharmaceutical Anti-Counterfeiting Solution Business (2021-2026)
- 12.13.4 Constantia Flexibles Pharmaceutical Anti-Counterfeiting Solution Product Portfolio
- 12.13.5 Constantia Flexibles Recent Developments
- 12.14 Arjo Solution
- 12.14.1 Arjo Solution Company Information
- 12.14.2 Arjo Solution Business Overview
- 12.14.3 Arjo Solution Revenue in Pharmaceutical Anti-Counterfeiting Solution Business (2021-2026)
- 12.14.4 Arjo Solution Pharmaceutical Anti-Counterfeiting Solution Product Portfolio
- 12.14.5 Arjo Solution Recent Developments
- 12.15 SafeTraces
- 12.15.1 SafeTraces Company Information
- 12.15.2 SafeTraces Business Overview
- 12.15.3 SafeTraces Revenue in Pharmaceutical Anti-Counterfeiting Solution Business (2021-2026)
- 12.15.4 SafeTraces Pharmaceutical Anti-Counterfeiting Solution Product Portfolio
- 12.15.5 SafeTraces Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst